These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12902169)

  • 21. Streamlining drug discovery: finding the right drug against the right target to treat the right disease.
    Ng JH; Ilag LL
    Drug Discov Today; 2004 Jan; 9(2):59-60. PubMed ID: 15025066
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organotypic cultures as tools for functional screening in the CNS.
    Sundstrom L; Morrison B; Bradley M; Pringle A
    Drug Discov Today; 2005 Jul; 10(14):993-1000. PubMed ID: 16023058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics: where did we go wrong?
    Overbye KM; Barrett JF
    Drug Discov Today; 2005 Jan; 10(1):45-52. PubMed ID: 15676298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative proteomics for drug toxicity.
    Gao Y; Holland RD; Yu LR
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and perspectives of scientific services offered by genomic biological resource centres.
    Wagner F; Heidtke KR; Drescher B; Radelof U
    Brief Funct Genomic Proteomic; 2007 Sep; 6(3):163-70. PubMed ID: 17967806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomics and proteomics in process development: opportunities and challenges.
    Gupta P; Lee KH
    Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the impact of genomics on drug discovery and development.
    Crooke ST
    Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260
    [No Abstract]   [Full Text] [Related]  

  • 30. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
    Brown D
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How many genomics targets can a portfolio afford?
    Betz UA
    Drug Discov Today; 2005 Aug; 10(15):1057-63. PubMed ID: 16055022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the complete determination of biological systems.
    Selinger DW; Wright MA; Church GM
    Trends Biotechnol; 2003 Jun; 21(6):251-4. PubMed ID: 12788544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The challenges of modeling mammalian biocomplexity.
    Nicholson JK; Holmes E; Lindon JC; Wilson ID
    Nat Biotechnol; 2004 Oct; 22(10):1268-74. PubMed ID: 15470467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Main approaches to target discovery and validation.
    Sioud M
    Methods Mol Biol; 2007; 360():1-12. PubMed ID: 17172722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of constitutively active GPCRs in drug discovery and functional genomics.
    Chalmers DT; Behan DP
    Nat Rev Drug Discov; 2002 Aug; 1(8):599-608. PubMed ID: 12402500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond the genome--SMi Conference 27-28 January 2003, London, UK.
    Swinton J; Sheridan JM; Henning SW
    IDrugs; 2003 Mar; 6(3):203-6. PubMed ID: 12838986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ultimate model organism: progress in experimental medicine.
    Littman BH; Williams SA
    Nat Rev Drug Discov; 2005 Aug; 4(8):631-8. PubMed ID: 16056389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protozoan genomics for drug discovery.
    Chaudhary K; Roos DS
    Nat Biotechnol; 2005 Sep; 23(9):1089-91. PubMed ID: 16151400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.